跳至主要内容
临床试验/NCT03414879
NCT03414879已完成4 期

Ketamine Versus Lidocaine Nebulization for Awake Nasal Fiberoptic Intubation: a Prospective, Randomized Double-blinded Study

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Dose of supplemental lidocaine

研究概览

简要总结

This randomized double-blinded study is performed to compare ketamine versus lidocaine for nebulization for awake nasal fiberoptic intubation as regard efficacy and side effects.

详细描述

Difficult airway is one of the major challenges facing anesthesiologists. This challenge is compounded when the patient is treated while awake. The additional burden is to complete this procedure comfortably thus ensuring patient cooperation which is a vital part of successful performance. Several methods have been tried in literature to facilitate awake intubation by fiberoptic bronchoscope (FOB)

This randomized double-blinded study is performed to compare ketamine versus lidocaine for nebulization for awake nasal fiberoptic intubation as regard efficacy and side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status I and II of both sexes with body weight from 60-90 kg, and planned for elective awake nasal fiberoptic intubation due to expected difficulty in airway management (e.g. limited mouth opening, trismus, mandibular/ maxillary swellings or tumors, ludwig's angina, or other indications).

排除标准

  • body weight < 60 kg or > 90 kg
  • uncooperative, with mental or psychological problems
  • known allergy to any of the study drugs
  • pregnancy
  • hypertension
  • cardiac disease
  • liver or renal impairment
  • epilepsy,
  • asthmatic,
  • previous bad experience of awake intubation,
  • emergency operations or
  • coagulation abnormalities

研究组 & 干预措施

Ketamine group

Active Comparator

Nebulization with ketamine

干预措施: Ketamine (Drug)

Lidocaine group

Active Comparator

Nebulization with with lidocaine

干预措施: Lidocaine (Drug)

结局指标

主要结局

Dose of supplemental lidocaine

时间窗: Intraoperative

Dose of supplemental lidocaine during awake fiberoptic procedure

次要结局

  • Incidence of adverse events(Intraoperative)
  • Patient tolerability score(Intraoperative)
  • Patient satisfaction score(first 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayman Ahmad Alsayed Abdellatif

Assistant Professor

Ain Shams University

研究点 (1)

Loading locations...

相似试验